Re: UPI Version - Too bad they don't FACT CHECK!!!

[Guest guest]

As a minimum, I think it behooves the press to use the correct brand

name which is Gleevec in the USA.

Hope the drug does prve effective for these additional cancers!

>

>

> Novartis seeks Gleevac OK in 4 cancers

>

> NEW YORK, April 10 (UPI) -- Novartis is seeking approval in the United

> States and Europe to market cancer drug Gleevac for four additional

> cancer

> types.

>

> According to a report Monday in the Wall Street Journal, Novartis has

> filed

> for approval with the Food and Drug Administration and with European

> regulators for expanded use of Gleevac to treat a skin cancer known as

> dermatofibrosarcoma protuberans; and three blood cancers,

> hypereosinophilic

> syndrome, systemic mastocytosis and certain types of myeloproliferative

> disorders, the WSJ report said.

>

> Gleevac is currently approved to treat chronic myeloid leukemia and a

> type

> of stomach cancer known as GIST, the report said.

>

> Because the cancers for which Novartis is seeking additional approval

> are so

> rare, the company was unable to study Gleevac in thousands of patients

> as

> the FDA normally requires, but instead has submitted data from a series

> of

> small clinical trials conducted by the Swiss drug company and by

> independent

> researchers.

> Novartis' latest filings reflect a shift in how cancer should be

> treated,

> based on the belief that there are " hundreds of subgroups of cancer

> based

> more on genetic makeup than on location, " the WSJ reported.

>

> Thus, cancer treatment is starting to emphasize the genetic mutations

> involved in a specific cancer case, rather than on the organ in which

> the

> cancer is located, the report said.

>